Position
SIMPLEX TRADING, LLC in PharmaCyte Biotech, Inc.
Back to the book · All holders of PMCB
Estimated mark uses implied 13F prices (value ÷ shares). Adds are treated as happening at this quarter’s mark; cuts at last quarter’s. Share jumps can be splits, not buys. This is not realized P&L.
Latest estimated mark −$1.18K$0.72 → $0.66
| Quarter | Shares | Value | Implied px | Est. mark | Flow | Weight |
|---|---|---|---|---|---|---|
| Q4 2025 | 25.8K | $18.7K | — | — | — | 0.0% |
| Q1 2026 | 19.9K | $13.3K | $0.66 | −$1.18K | −$4.27K | 0.0% |